PLAL1_HUMAN
ID PLAL1_HUMAN Reviewed; 463 AA.
AC Q9UM63; B2RBA4; B2RCM8; E1P595; E1P597; O76019; Q7Z3V8; Q92981; Q96JR9;
AC Q9UIZ0;
DT 20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT 11-SEP-2007, sequence version 2.
DT 03-AUG-2022, entry version 186.
DE RecName: Full=Zinc finger protein PLAGL1;
DE AltName: Full=Lost on transformation 1;
DE Short=LOT-1;
DE AltName: Full=Pleiomorphic adenoma-like protein 1;
DE AltName: Full=Tumor suppressor ZAC;
GN Name=PLAGL1; Synonyms=LOT1, ZAC;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX PubMed=9150364; DOI=10.1038/sj.onc.1201034;
RA Abdollahi A., Roberts D., Godwin A.K., Schultz D.C., Sonoda G., Testa J.R.,
RA Hamilton T.C.;
RT "Identification of a zinc-finger gene at 6q25: a chromosomal region
RT implicated in development of many solid tumors.";
RL Oncogene 14:1973-1979(1997).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RX PubMed=9722527; DOI=10.1074/jbc.273.36.23026;
RA Kas K., Voz M.L., Hensen K., Meyen E., Van de Ven W.J.M.;
RT "Transcriptional activation capacity of the novel PLAG family of zinc
RT finger proteins.";
RL J. Biol. Chem. 273:23026-23032(1998).
RN [3]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC TISSUE=Pituitary;
RX PubMed=9671765; DOI=10.1073/pnas.95.15.8835;
RA Varrault A., Ciani E., Apiou F., Bilanges B., Hoffmann A., Pantaloni C.,
RA Bockaert J., Spengler D., Journot L.;
RT "hZAC encodes a zinc finger protein with antiproliferative properties and
RT maps to a chromosomal region frequently lost in cancer.";
RL Proc. Natl. Acad. Sci. U.S.A. 95:8835-8840(1998).
RN [4]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND SUBCELLULAR LOCATION.
RC TISSUE=Mammary gland;
RX PubMed=11313869; DOI=10.1038/sj.onc.1204237;
RA Bilanges B., Varrault A., Mazumdar A., Pantaloni C., Hoffmann A.,
RA Bockaert J., Spengler D., Journot L.;
RT "Alternative splicing of the imprinted candidate tumor suppressor gene ZAC
RT regulates its antiproliferative and DNA binding activities.";
RL Oncogene 20:1246-1253(2001).
RN [5]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC TISSUE=Placenta;
RA Varrault A., Bilanges B., Mackay D.J., Basyuk E., Ahr B., Fernandez C.,
RA Robinson D.O., Bockaert J., Journot L.;
RT "Characterization of the methylation-sensitive promoter of the imprinted
RT ZAC (PLAGL1) gene supports its role in transient neonatal diabetes
RT mellitus.";
RL Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN [6]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC TISSUE=Colon;
RX PubMed=14702039; DOI=10.1038/ng1285;
RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA Isogai T., Sugano S.;
RT "Complete sequencing and characterization of 21,243 full-length human
RT cDNAs.";
RL Nat. Genet. 36:40-45(2004).
RN [7]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC TISSUE=Fetal kidney;
RX PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA Wiemann S., Schupp I.;
RT "The full-ORF clone resource of the German cDNA consortium.";
RL BMC Genomics 8:399-399(2007).
RN [8]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=14574404; DOI=10.1038/nature02055;
RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA Rogers J., Beck S.;
RT "The DNA sequence and analysis of human chromosome 6.";
RL Nature 425:805-811(2003).
RN [9]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA Hunkapiller M.W., Myers E.W., Venter J.C.;
RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN [10]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC TISSUE=Lung;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [11]
RP INVOLVEMENT IN TNDM1.
RX PubMed=11935319; DOI=10.1007/s00439-001-0671-5;
RA Mackay D.J., Coupe A.M., Shield J.P., Storr J.N., Temple I.K.,
RA Robinson D.O.;
RT "Relaxation of imprinted expression of ZAC and HYMAI in a patient with
RT transient neonatal diabetes mellitus.";
RL Hum. Genet. 110:139-144(2002).
RN [12]
RP FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH THRSP.
RX PubMed=18299245; DOI=10.1016/j.biocel.2008.01.014;
RA Chou W.Y., Ho C.L., Tseng M.L., Liu S.T., Yen L.C., Huang S.M.;
RT "Human Spot 14 protein is a p53-dependent transcriptional coactivator via
RT the recruitment of thyroid receptor and Zac1.";
RL Int. J. Biochem. Cell Biol. 40:1826-1834(2008).
RN [13]
RP INVOLVEMENT IN TNDM1.
RX PubMed=18622393; DOI=10.1038/ng.187;
RA Mackay D.J.G., Callaway J.L.A., Marks S.M., White H.E., Acerini C.L.,
RA Boonen S.E., Dayanikli P., Firth H.V., Goodship J.A., Haemers A.P.,
RA Hahnemann J.M.D., Kordonouri O., Masoud A.F., Oestergaard E., Storr J.,
RA Ellard S., Hattersley A.T., Robinson D.O., Temple I.K.;
RT "Hypomethylation of multiple imprinted loci in individuals with transient
RT neonatal diabetes is associated with mutations in ZFP57.";
RL Nat. Genet. 40:949-951(2008).
CC -!- FUNCTION: Acts as a transcriptional activator (PubMed:9722527).
CC Involved in the transcriptional regulation of type 1 receptor for
CC pituitary adenylate cyclase-activating polypeptide.
CC {ECO:0000269|PubMed:18299245, ECO:0000269|PubMed:9722527}.
CC -!- SUBUNIT: Interacts with THRSP. {ECO:0000269|PubMed:18299245}.
CC -!- INTERACTION:
CC Q9UM63; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-7233410, EBI-2556193;
CC Q9UM63; Q08117-2: TLE5; NbExp=3; IntAct=EBI-7233410, EBI-11741437;
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11313869,
CC ECO:0000269|PubMed:18299245}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=2;
CC Name=1;
CC IsoId=Q9UM63-1; Sequence=Displayed;
CC Name=2; Synonyms=ZACdelta2;
CC IsoId=Q9UM63-2; Sequence=VSP_028123;
CC -!- DISEASE: Diabetes mellitus, transient neonatal, 1 (TNDM1) [MIM:601410]:
CC An autosomal dominant form of diabetes mellitus defined by the onset of
CC mild-to-severe hyperglycemia within the first month of life. In about
CC half of the neonates, diabetes is transient and resolves at a median
CC age of 3 months, whereas the rest have a permanent form of diabetes.
CC {ECO:0000269|PubMed:11935319}. Note=The gene represented in this entry
CC is involved in disease pathogenesis. Imprinted expression of PLAGL1 is
CC relaxed in patients with transient neonatal diabetes (TND)
CC (PubMed:11935319). Aberrant hypomethylation of the TND differentially
CC methylated region within the PLAGL1 promoter as well as other imprinted
CC loci at chromosome 6q24 is caused by ZFP57 mutations (PubMed:18622393).
CC {ECO:0000269|PubMed:11935319, ECO:0000269|PubMed:18622393}.
CC -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC family. {ECO:0000305}.
CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC Haematology;
CC URL="http://atlasgeneticsoncology.org/Genes/PLAGL1ID41737ch6q24.html";
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U72621; AAB67041.1; -; mRNA.
DR EMBL; U81992; AAC34250.1; -; mRNA.
DR EMBL; AJ006354; CAA06994.1; -; mRNA.
DR EMBL; AJ303119; CAC39614.1; -; mRNA.
DR EMBL; AJ311395; CAC39615.1; -; mRNA.
DR EMBL; AK314570; BAG37151.1; -; mRNA.
DR EMBL; AK315184; BAG37625.1; -; mRNA.
DR EMBL; BX537397; CAD97639.1; -; mRNA.
DR EMBL; AL049844; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; CH471051; EAW47852.1; -; Genomic_DNA.
DR EMBL; CH471051; EAW47853.1; -; Genomic_DNA.
DR EMBL; CH471051; EAW47854.1; -; Genomic_DNA.
DR EMBL; CH471051; EAW47855.1; -; Genomic_DNA.
DR EMBL; CH471051; EAW47856.1; -; Genomic_DNA.
DR EMBL; BC074814; AAH74814.1; -; mRNA.
DR EMBL; BC109085; AAI09086.1; -; mRNA.
DR EMBL; BC109086; AAI09087.1; -; mRNA.
DR CCDS; CCDS5202.1; -. [Q9UM63-1]
DR CCDS; CCDS5203.1; -. [Q9UM63-2]
DR RefSeq; NP_001074420.1; NM_001080951.2. [Q9UM63-1]
DR RefSeq; NP_001074421.1; NM_001080952.2. [Q9UM63-1]
DR RefSeq; NP_001074422.1; NM_001080953.2. [Q9UM63-1]
DR RefSeq; NP_001074423.1; NM_001080954.2. [Q9UM63-1]
DR RefSeq; NP_001074424.1; NM_001080955.2. [Q9UM63-2]
DR RefSeq; NP_001074425.1; NM_001080956.2. [Q9UM63-2]
DR RefSeq; NP_001275966.1; NM_001289037.1. [Q9UM63-2]
DR RefSeq; NP_001275967.1; NM_001289038.1. [Q9UM63-2]
DR RefSeq; NP_001275968.1; NM_001289039.1. [Q9UM63-2]
DR RefSeq; NP_001275969.1; NM_001289040.1. [Q9UM63-2]
DR RefSeq; NP_001275970.1; NM_001289041.1. [Q9UM63-2]
DR RefSeq; NP_001275971.1; NM_001289042.1. [Q9UM63-1]
DR RefSeq; NP_001275972.1; NM_001289043.1. [Q9UM63-1]
DR RefSeq; NP_001275973.1; NM_001289044.1. [Q9UM63-1]
DR RefSeq; NP_001275974.1; NM_001289045.1. [Q9UM63-1]
DR RefSeq; NP_001275975.1; NM_001289046.1. [Q9UM63-1]
DR RefSeq; NP_001275976.1; NM_001289047.1. [Q9UM63-1]
DR RefSeq; NP_001275977.1; NM_001289048.1. [Q9UM63-1]
DR RefSeq; NP_001275978.1; NM_001289049.1. [Q9UM63-1]
DR RefSeq; NP_001304085.1; NM_001317156.1. [Q9UM63-1]
DR RefSeq; NP_001304086.1; NM_001317157.1. [Q9UM63-1]
DR RefSeq; NP_001304087.1; NM_001317158.1. [Q9UM63-2]
DR RefSeq; NP_001304088.1; NM_001317159.1. [Q9UM63-1]
DR RefSeq; NP_001304089.1; NM_001317160.1. [Q9UM63-2]
DR RefSeq; NP_001304090.1; NM_001317161.1. [Q9UM63-1]
DR RefSeq; NP_001304091.1; NM_001317162.1. [Q9UM63-1]
DR RefSeq; NP_006709.2; NM_006718.4. [Q9UM63-1]
DR AlphaFoldDB; Q9UM63; -.
DR SMR; Q9UM63; -.
DR BioGRID; 111341; 15.
DR IntAct; Q9UM63; 3.
DR MINT; Q9UM63; -.
DR STRING; 9606.ENSP00000353734; -.
DR iPTMnet; Q9UM63; -.
DR PhosphoSitePlus; Q9UM63; -.
DR BioMuta; PLAGL1; -.
DR DMDM; 158523334; -.
DR EPD; Q9UM63; -.
DR jPOST; Q9UM63; -.
DR MassIVE; Q9UM63; -.
DR MaxQB; Q9UM63; -.
DR PaxDb; Q9UM63; -.
DR PeptideAtlas; Q9UM63; -.
DR PRIDE; Q9UM63; -.
DR ProteomicsDB; 85183; -. [Q9UM63-1]
DR ProteomicsDB; 85184; -. [Q9UM63-2]
DR Antibodypedia; 19825; 236 antibodies from 30 providers.
DR DNASU; 5325; -.
DR Ensembl; ENST00000354765.6; ENSP00000346810.2; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000360537.6; ENSP00000353734.2; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000367571.3; ENSP00000356543.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000367572.3; ENSP00000356544.1; ENSG00000118495.21. [Q9UM63-2]
DR Ensembl; ENST00000416623.5; ENSP00000400060.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000417959.4; ENSP00000395960.2; ENSG00000118495.21. [Q9UM63-2]
DR Ensembl; ENST00000437412.5; ENSP00000392418.1; ENSG00000118495.21. [Q9UM63-2]
DR Ensembl; ENST00000444202.5; ENSP00000400929.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000625622.2; ENSP00000486355.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000647880.1; ENSP00000496815.1; ENSG00000118495.21. [Q9UM63-2]
DR Ensembl; ENST00000649211.1; ENSP00000497492.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000649307.1; ENSP00000496979.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000650125.1; ENSP00000497363.1; ENSG00000118495.21. [Q9UM63-1]
DR Ensembl; ENST00000674357.1; ENSP00000501459.1; ENSG00000118495.21. [Q9UM63-1]
DR GeneID; 5325; -.
DR KEGG; hsa:5325; -.
DR MANE-Select; ENST00000674357.1; ENSP00000501459.1; NM_001317162.2; NP_001304091.1.
DR UCSC; uc003qjv.4; human. [Q9UM63-1]
DR CTD; 5325; -.
DR DisGeNET; 5325; -.
DR GeneCards; PLAGL1; -.
DR GeneReviews; PLAGL1; -.
DR HGNC; HGNC:9046; PLAGL1.
DR HPA; ENSG00000118495; Tissue enhanced (placenta).
DR MalaCards; PLAGL1; -.
DR MIM; 601410; phenotype.
DR MIM; 603044; gene.
DR neXtProt; NX_Q9UM63; -.
DR OpenTargets; ENSG00000118495; -.
DR Orphanet; 96191; Paternal uniparental disomy of chromosome 6.
DR Orphanet; 99886; Transient neonatal diabetes mellitus.
DR PharmGKB; PA33379; -.
DR VEuPathDB; HostDB:ENSG00000118495; -.
DR eggNOG; KOG1721; Eukaryota.
DR GeneTree; ENSGT00940000162004; -.
DR HOGENOM; CLU_002678_66_1_1; -.
DR InParanoid; Q9UM63; -.
DR OMA; ITMAFGP; -.
DR PhylomeDB; Q9UM63; -.
DR TreeFam; TF332024; -.
DR PathwayCommons; Q9UM63; -.
DR Reactome; R-HSA-6804115; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain.
DR SignaLink; Q9UM63; -.
DR SIGNOR; Q9UM63; -.
DR BioGRID-ORCS; 5325; 13 hits in 1100 CRISPR screens.
DR ChiTaRS; PLAGL1; human.
DR GeneWiki; PLAGL1; -.
DR GenomeRNAi; 5325; -.
DR Pharos; Q9UM63; Tbio.
DR PRO; PR:Q9UM63; -.
DR Proteomes; UP000005640; Chromosome 6.
DR RNAct; Q9UM63; protein.
DR Bgee; ENSG00000118495; Expressed in adrenal tissue and 196 other tissues.
DR ExpressionAtlas; Q9UM63; baseline and differential.
DR Genevisible; Q9UM63; HS.
DR GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR GO; GO:0016604; C:nuclear body; IDA:HPA.
DR GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR GO; GO:0003677; F:DNA binding; IDA:MGI.
DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IBA:GO_Central.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR GO; GO:0051726; P:regulation of cell cycle; TAS:ProtInc.
DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR InterPro; IPR027770; PLAGL1.
DR InterPro; IPR036236; Znf_C2H2_sf.
DR InterPro; IPR013087; Znf_C2H2_type.
DR PANTHER; PTHR24399:SF31; PTHR24399:SF31; 1.
DR Pfam; PF00096; zf-C2H2; 2.
DR SMART; SM00355; ZnF_C2H2; 7.
DR SUPFAM; SSF57667; SSF57667; 3.
DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 7.
DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE 1: Evidence at protein level;
KW Activator; Alternative splicing; Diabetes mellitus; DNA-binding;
KW Metal-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW Transcription regulation; Zinc; Zinc-finger.
FT CHAIN 1..463
FT /note="Zinc finger protein PLAGL1"
FT /id="PRO_0000047222"
FT ZN_FING 4..26
FT /note="C2H2-type 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT ZN_FING 32..56
FT /note="C2H2-type 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT ZN_FING 62..84
FT /note="C2H2-type 3"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT ZN_FING 91..113
FT /note="C2H2-type 4"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT ZN_FING 120..142
FT /note="C2H2-type 5"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT ZN_FING 156..178
FT /note="C2H2-type 6"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT ZN_FING 184..207
FT /note="C2H2-type 7"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT REGION 268..306
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT VAR_SEQ 1..52
FT /note="Missing (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:11313869,
FT ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17974005,
FT ECO:0000303|PubMed:9722527"
FT /id="VSP_028123"
FT VARIANT 272
FT /note="A -> V (in dbSNP:rs35263016)"
FT /id="VAR_052729"
FT CONFLICT 81
FT /note="L -> F (in Ref. 1; AAB67041)"
FT /evidence="ECO:0000305"
FT CONFLICT 197
FT /note="D -> V (in Ref. 2; AAC34250)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 463 AA; 50819 MW; B10C74DA409BD4F7 CRC64;
MATFPCQLCG KTFLTLEKFT IHNYSHSRER PYKCVQPDCG KAFVSRYKLM RHMATHSPQK
SHQCAHCEKT FNRKDHLKNH LQTHDPNKMA FGCEECGKKY NTMLGYKRHL ALHAASSGDL
TCGVCALELG STEVLLDHLK AHAEEKPPSG TKEKKHQCDH CERCFYTRKD VRRHLVVHTG
CKDFLCQFCA QRFGRKDHLT RHTKKTHSQE LMKESLQTGD LLSTFHTISP SFQLKAAALP
PFPLGASAQN GLASSLPAEV HSLTLSPPEQ AAQPMQPLPE SLASLHPSVS PGSPPPPLPN
HKYNTTSTSY SPLASLPLKA DTKGFCNISL FEDLPLQEPQ SPQKLNPGFD LAKGNAGKVN
LPKELPADAV NLTIPASLDL SPLLGFWQLP PPATQNTFGN STLALGPGES LPHRLSCLGQ
QQQEPPLAMG TVSLGQLPLP PIPHVFSAGT GSAILPHFHH AFR
